BIONIK Inc. was founded in 2011 in Toronto initially focusing on exoskeletal and other assistive technologies. In 2016 BIONIK acquired Interactive Motion Technologies (IMT), a global pioneer in the world of rehabilitation robotics. The InMotion Robots of today were first developed as an MIT research project called the MIT MANUS. In the early 1990’s, MIT MANUS was the first rehabilitation robot to be deployed in clinical trials. Based on what are now modern-day multiple neuroscientific principles, the MIT MANUS introduced a number of innovations, such as increasing ten-fold the number of repetitions possible per session, and the concept of “Assist-as-needed” technology.
Featured in more that 250 peer reviewed journals involving more than 1,000 patients, the InMotion® Robots are the most thoroughly researched upper-extremity robotic therapy device. This vast body of clinical research shows that the InMotion Robots are suitable for a broad range of patients suffering from Stroke, Spinal Cord Injury, Cerebral Palsy, Acquired Brain Injury and other neurological disorders. Hundreds of InMotion Robots are now in use in 20 countries around the world.
BIONIK is proud to be returning to MEDICA! We look forward to further expanding into Europe and strengthening our partnerships there.